Biotech

All Articles

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals called "spectacular" period 1/2 data for its own 31-valent pn...

Recursion's brain illness trial reveals insufficient documentation of effectiveness

.Recursion has discovered via an early test of its own tech-enabled strategy to medicine discovery, ...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it an instance of great chemistry: Acepodia, a biotech based upon Nobel Champion science, i...

Praxis epilepsy drug reduces seizures in phase 2 litigation

.Practice Preciseness Medicines has actually scored another midphase win in epilepsy this year, with...

Three directors resign as Dyne posts mixed records for DMD candidate

.After leaving a medical grip several years back, Dyne Rehab has actually uncovered new stage 1/2 in...

Arrowhead fires off period 3 information in rare metabolic health condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in advance of a prospective face-off with Ionis...

Pfizer, Valneva present lyme health condition shot efficient for 2nd enhancer

.Pfizer and Valneva might possess concerning 2 additional years to wait just before they create the ...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Fierce Biotech Editor-in-Chief and also Michelle...

New records show how Bayer's asundexian fell short to stop movements

.Bayer suspended the stage 3 test for its own aspect XIa prevention asundexian behind time in 2014 a...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own a number of sclerosis (MS) med tolebrutinib to the F...